cerrar
Tagged with OP

The Ideal Pharma Country Manager: South Korea (DHR International)
Looking at what it takes to be a country manager of a multinational pharma company in some of the world’s most challenging markets. DHR…

The European Medicines Verification System Launches to Tackle…
The 9th February 2019 marked the launch of the European Medicines Verification System (EMVS) which will use cutting-edge technology to safeguard the…

5 Biotechs to Watch in China
Even though China’s pharmaceutical sector remains largely generics-based, the Middle Kingdom’s biotechnology scene has been flourishing in recent…

“Watch Out! Unsophisticated AI in Healthcare Can Perpetuate…
As the healthcare industry continues to hype about AI's potential to be transformative, it is important to remember that even software can harbour a…

India’s Drug Regulatory Reforms: Building Trust
Dilip Shah, the Secretary-General of the Indian Pharmaceutical Alliance advocates for a stronger and more empowered regulator in India if the country…

Top 20 Pharma Companies in France (2018)
The Top 20 pharma companies in France, ranked by total turnover at ex-manufacturer prices for 2018. Swiss giant Novartis is in first place with a EUR…

Mexico’s Healthcare System: Perspectives from the Pharma…
Cristobal Thompson is the Executive Director at AMIIF (Asociacion Mexicana de Industrias de Investigacion Farmaceutica). The AMIIF represents more…

Megatrends from the 2019 Deloitte Life Sciences Outlook
Deloitte's Global Life Sciences & Health Care industry leader, Greg Reh gives us an exclusive insight into their forecast for 2019's industry…

Investing in Canadian Health: We Know the Cost, but Can We Talk…
As the President of Innovative Medicines Canada, Pamela Fralick leads the industry association for Canada’s innovative pharmaceutical companies,…

Year in Review – Transformational Transactions Dominated…
Christoph Bieri, PhD is Managing Partner of Kurmann Partners, an M&A firm advising Pharma and MedTech companies on strategic mid-market deals in…

The Pharmacy in 2019
Meghann Chilcott, Chief Technology/Marketing Officer at Benzer Pharmacy looks at current pharmaceutical service trends that aim to create a more…

“Restricting Drug Patent Settlements is Bad for US…
Chester “Chip” Davis, Jr, the President and CEO of the Association for Accessible Medicines (AAM) in the US urges Congress to avoid restricting…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here